Hennings, J M
Uhr, M
Klengel, T
Weber, P
Pütz, B
Touma, C
Czamara, D
Ising, M
Holsboer, F
Lucae, S
Article History
Received: 16 September 2014
Revised: 5 December 2014
Accepted: 19 December 2014
First Online: 31 March 2015
Competing interests
: DC was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy). JMH has received travel support to scientific congresses from Eli Lilly, Bayer Vital and Novartis. FH reported his patent: Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (TESI). European application number: 08016477.5. International application number: PCT/EP2009/061575. MU is patent holder of WO2005/108605A2 and WO2008/151803A2. Parts of the study were supported by the Molecular Diagnostics program of the German Federal Ministry of Education and Research (BMBF), project no. 01ES0811. The remaining authors declare no conflict of interest.